Your browser doesn't support javascript.
loading
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children.
Frémond, Marie-Louise; Rodero, Mathieu Paul; Jeremiah, Nadia; Belot, Alexandre; Jeziorski, Eric; Duffy, Darragh; Bessis, Didier; Cros, Guilhem; Rice, Gillian I; Charbit, Bruno; Hulin, Anne; Khoudour, Nihel; Caballero, Consuelo Modesto; Bodemer, Christine; Fabre, Monique; Berteloot, Laureline; Le Bourgeois, Muriel; Reix, Philippe; Walzer, Thierry; Moshous, Despina; Blanche, Stéphane; Fischer, Alain; Bader-Meunier, Brigitte; Rieux-Laucat, Fréderic; Crow, Yanick Joseph; Neven, Bénédicte.
Afiliación
  • Frémond ML; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Paris, France; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, France.
  • Rodero MP; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, France.
  • Jeremiah N; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity, Paris, France.
  • Belot A; Pediatric Rheumatology, Nephrology and Dermatology Department, Hospices Civils de Lyon, Lyon, France; CIRI, Centre International de Recherche en Infectiologie, INSERM, U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon 1, Lyon, France.
  • Jeziorski E; Pediatrics Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Duffy D; INSERM U1223, Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris, France; Center for Translational Research, Institut Pasteur, Paris, France.
  • Bessis D; Dermatology Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Cros G; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Paris, France.
  • Rice GI; Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom.
  • Charbit B; INSERM U1223, Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris, France.
  • Hulin A; Pharmacology and Toxicology Laboratory, Hôpital Universitaire Henri Mondor, Créteil, France.
  • Khoudour N; Pharmacology and Toxicology Laboratory, Hôpital Universitaire Henri Mondor, Créteil, France.
  • Caballero CM; Pediatric Rheumatology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Bodemer C; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; Department of Dermatology, Hôpital Necker-Enfants Malades, Paris, France.
  • Fabre M; Department of Pathology, Hôpital Necker-Enfants Malades, Paris, France.
  • Berteloot L; Department of Pediatric Radiology, Hôpital Necker-Enfants Malades, Paris, France.
  • Le Bourgeois M; Department of Pediatric Pneumology, Hôpital Necker-Enfants Malades, Paris, France.
  • Reix P; Pneumology Department, Centre de Référence de la Mucoviscidose, Hospices Civils de Lyon and Claude-Bernard Lyon 1 University, Lyon, France.
  • Walzer T; CIRI, Centre International de Recherche en Infectiologie, INSERM, U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon 1, Lyon, France.
  • Moshous D; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Paris, France; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Laboratory of Genome Dynamics in the Immune System, Paris, France.
  • Blanche S; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Paris, France; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France.
  • Fischer A; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Paris, France; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Paris, France; Collège de France, Paris, France.
  • Bader-Meunier B; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Paris, France; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity, Paris, France.
  • Rieux-Laucat F; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity, Paris, France.
  • Crow YJ; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Laboratory of Neurogenetics and Neuroinflammation, Paris, France; Manchester Centre for Genomic Medicine, Institute of Human Development, Faculty of Medical and Human Sciences, Manchester Academic Heal
  • Neven B; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Paris, France; Paris Descartes University, Sorbonne-Paris-Cité, Institut Imagine, Paris, France; INSERM UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity, Paris, France. Electronic address: be
J Allergy Clin Immunol ; 138(6): 1752-1755, 2016 12.
Article en En | MEDLINE | ID: mdl-27554814
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Inhibidores de Proteínas Quinasas / Janus Quinasa 1 / Janus Quinasa 2 / Proteínas de la Membrana / Mutación Tipo de estudio: Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Año: 2016 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Inhibidores de Proteínas Quinasas / Janus Quinasa 1 / Janus Quinasa 2 / Proteínas de la Membrana / Mutación Tipo de estudio: Risk_factors_studies Límite: Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Año: 2016 Tipo del documento: Article País de afiliación: Francia